WallStSmart
GRAL

GRAIL, LLC

NASDAQ: GRAL · HEALTHCARE · DIAGNOSTICS & RESEARCH

$49.69
-4.81% today

Updated 2026-04-29

Market cap
$2.14B
P/E ratio
—
P/S ratio
14.55x
EPS (TTM)
$-11.11
Dividend yield
—
52W range
$30 – $119
Volume
1.4M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

GRAIL, LLC (GRAL) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item20182019202020212022202320242025
Revenue—$0.00—$14.61M$55.55M$93.11M$125.59M$147.17M
Revenue growth (YoY)————+280.2%+67.6%+34.9%+17.2%
Cost of revenue$14.08M$10.31M—$114.61M$172.00M$188.72M$203.62M$209.75M
Gross profit$-14.08M$-10.31M—$-100.00M$-116.45M$-95.61M$-78.02M$-62.57M
Gross margin———-684.4%-209.6%-102.7%-62.1%-42.5%
R&D$223.16M$167.09M$192.91M$460.21M$329.58M$338.75M$322.38M$195.79M
SG&A$58.23M$80.90M$110.03M$180.53M$174.11M$200.27M$213.86M$159.10M
Operating income$-287.50M$-255.66M$-316.42M$-1.27B$-5.44B$-1.52B$-2.19B$-534.16M
Operating margin———-8659.6%-9798.2%-1627.6%-1743.0%-363.0%
EBITDA$-269.42M$-243.14M$-308.73M$-1.21B$-587.70M$-638.22M$-610.17M$-377.82M
EBITDA margin———-8259.0%-1058.0%-685.5%-485.8%-256.7%
EBIT$-283.50M$-253.44M$-316.30M$-1.27B$-742.46M$-796.92M$-768.22M$-534.16M
Interest expense————————
Income tax$485000.00$-195000.00$33000.00$-17.48M$-42.29M$-41.95M$-135.36M$126.15M
Effective tax rate-0.2%0.1%-0.0%1.4%0.8%2.8%6.3%-44.7%
Net income$-275.72M$-244.85M$-312.16M$-1.25B$-5.40B$-1.47B$-2.03B$-408.35M
Net income growth (YoY)—+11.2%-27.5%-299.7%-332.7%+72.9%-38.3%+79.9%
Profit margin———-8539.4%-9719.3%-1574.2%-1613.9%-277.5%